These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 30115393)

  • 21. Towards an SI-Traceable Reference Measurement System for Seven Serum Apolipoproteins Using Bottom-Up Quantitative Proteomics: Conceptual Approach Enabled by Cross-Disciplinary/Cross-Sector Collaboration.
    Cobbaert CM; Althaus H; Begcevic Brkovic I; Ceglarek U; Coassin S; Delatour V; Deprez L; Dikaios I; Dittrich J; Hoofnagle AN; Kostner GM; Kronenberg F; Kuklenyik Z; Prinzing U; Vesper HW; Zegers I; Ruhaak LR;
    Clin Chem; 2021 Mar; 67(3):478-489. PubMed ID: 33331636
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evolution of Myeloma Testing in Clinical Chemistry with Mass Spectrometry.
    Murray DL; Willrich MAV
    J Appl Lab Med; 2019 Nov; 4(3):474-476. PubMed ID: 31659091
    [No Abstract]   [Full Text] [Related]  

  • 23. Isotope dilution mass spectrometry for absolute quantification in proteomics: concepts and strategies.
    Villanueva J; Carrascal M; Abian J
    J Proteomics; 2014 Jan; 96():184-99. PubMed ID: 24231108
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A mass graph-based approach for the identification of modified proteoforms using top-down tandem mass spectra.
    Kou Q; Wu S; Tolic N; Paša-Tolic L; Liu Y; Liu X
    Bioinformatics; 2017 May; 33(9):1309-1316. PubMed ID: 28453668
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systematic detection of functional proteoform groups from bottom-up proteomic datasets.
    Bludau I; Frank M; Dörig C; Cai Y; Heusel M; Rosenberger G; Picotti P; Collins BC; Röst H; Aebersold R
    Nat Commun; 2021 Jun; 12(1):3810. PubMed ID: 34155216
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Progress in Top-Down Proteomics and the Analysis of Proteoforms.
    Toby TK; Fornelli L; Kelleher NL
    Annu Rev Anal Chem (Palo Alto Calif); 2016 Jun; 9(1):499-519. PubMed ID: 27306313
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantitative analysis of human salivary gland-derived intact proteome using top-down mass spectrometry.
    Wu S; Brown JN; Tolić N; Meng D; Liu X; Zhang H; Zhao R; Moore RJ; Pevzner P; Smith RD; Paša-Tolić L
    Proteomics; 2014 May; 14(10):1211-22. PubMed ID: 24591407
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optimizing the SWATH-MS-workflow for label-free proteomics.
    Simbürger JMB; Dettmer K; Oefner PJ; Reinders J
    J Proteomics; 2016 Aug; 145():137-140. PubMed ID: 27107778
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Guidelines for reporting the use of mass spectrometry in proteomics.
    Taylor CF; Binz PA; Aebersold R; Affolter M; Barkovich R; Deutsch EW; Horn DM; Hühmer A; Kussmann M; Lilley K; Macht M; Mann M; Müller D; Neubert TA; Nickson J; Patterson SD; Raso R; Resing K; Seymour SL; Tsugita A; Xenarios I; Zeng R; Julian RK
    Nat Biotechnol; 2008 Aug; 26(8):860-1. PubMed ID: 18688232
    [No Abstract]   [Full Text] [Related]  

  • 30. Considering the advantages and pitfalls of the use of isotopically labeled protein standards for accurate protein quantification.
    Pritchard C; Quaglia M; Ashcroft AE; O'Connor G
    Bioanalysis; 2011 Dec; 3(24):2797-802. PubMed ID: 22185279
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of protein and peptide separation before mass spectrometry analysis in clinical proteomics.
    Camerini S; Mauri P
    J Chromatogr A; 2015 Feb; 1381():1-12. PubMed ID: 25618357
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proteomics in clinical chemistry: will it be long?
    Lescuyer P; Farina A; Hochstrasser DF
    Trends Biotechnol; 2010 May; 28(5):225-9. PubMed ID: 20359762
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New and emerging technologies for clinical proteomics.
    Stastna M; Van Eyk JE
    Proteomics Clin Appl; 2012 Dec; 6(11-12):547. PubMed ID: 23255386
    [No Abstract]   [Full Text] [Related]  

  • 34. Data standards and controlled vocabularies for proteomics.
    Martens L; Palazzi LM; Hermjakob H
    Methods Mol Biol; 2008; 484():279-86. PubMed ID: 18592186
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High-Throughput Analysis of Intact Human Proteins Using UVPD and HCD on an Orbitrap Mass Spectrometer.
    Cleland TP; DeHart CJ; Fellers RT; VanNispen AJ; Greer JB; LeDuc RD; Parker WR; Thomas PM; Kelleher NL; Brodbelt JS
    J Proteome Res; 2017 May; 16(5):2072-2079. PubMed ID: 28412815
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mass spectrometric immunoassays for discovery, screening and quantification of clinically relevant proteoforms.
    Trenchevska O; Nelson RW; Nedelkov D
    Bioanalysis; 2016 Aug; 8(15):1623-1633. PubMed ID: 27396364
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Standard Proteoforms and Their Complexes for Native Mass Spectrometry.
    Schachner LF; Ives AN; McGee JP; Melani RD; Kafader JO; Compton PD; Patrie SM; Kelleher NL
    J Am Soc Mass Spectrom; 2019 Jul; 30(7):1190-1198. PubMed ID: 30963455
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Guidelines for reporting the use of mass spectrometry informatics in proteomics.
    Binz PA; Barkovich R; Beavis RC; Creasy D; Horn DM; Julian RK; Seymour SL; Taylor CF; Vandenbrouck Y
    Nat Biotechnol; 2008 Aug; 26(8):862. PubMed ID: 18688233
    [No Abstract]   [Full Text] [Related]  

  • 39. Four areas of engagement requiring strengthening in modern proteomics today.
    Fehniger TE; Boja ES; Rodriguez H; Baker MS; Marko-Varga G
    J Proteome Res; 2014 Dec; 13(12):5310-8. PubMed ID: 25405748
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Data standardization by the HUPO-PSI: how has the community benefitted?
    Orchard S; Hermjakob H
    Methods Mol Biol; 2011; 696():149-60. PubMed ID: 21063946
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.